Can Follow-Up be Avoided for Probably Benign US Masses with No Enhancement on MRI?

OBJECTIVES: To assess whether no enhancement on pre-treatment MRI can rule out malignancy of additional US mass(es) initially assessed as BI-RADS 3 or 4 in women with newly diagnosed breast cancer. METHODS: This retrospective study included consecutive women from 2010–2018 with: newly diagnosed brea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur Radiol
Egile Nagusiak: Avendano, Daly, Marino, Maria Adele, Onishi, Natsuko, Leithner, Doris, Martinez, Danny F, Gibbs, Peter, Jochelson, Maxine, Pinker, Katja, Morris, Elizabeth A, Sutton, Elizabeth Jane
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7855658/
https://ncbi.nlm.nih.gov/pubmed/32870394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-020-07216-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak